CEPI reinvests in UQ's second-generation molecular clamp vaccine platform

November 28, 2022 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

UQ halted the development of the vaccine in response to false positives of HIV but CEPI said the molecular clamp technology remains a promising platform because it could enable rapid vaccine production against multiple viral pathogens. …

Subscribe now to continue reading.

Latest Video

What is it with this organisation's obsession with pharmacy and Europe?
July 13, 2026 - Latest News
Mesoblast reports strong cell therapy revenue as first year as uptake grows
July 13, 2026 - Latest News
Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers
July 13, 2026 - Latest News
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - Latest News
The age-old argument for supermarket pharmacies misses the point, and the risks
July 14, 2026 - Latest News

CEPI reinvests in UQ's second-generation molecular clamp vaccine platform

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials

Sign In

CEPI reinvests in UQ's second-generation molecular clamp vaccine platform

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

Follow Us

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials